Page last updated: 2024-09-04

mrz 2549 and u-50488

mrz 2549 has been researched along with u-50488 in 1 studies

Compound Research Comparison

Studies
(mrz 2549)
Trials
(mrz 2549)
Recent Studies (post-2010)
(mrz 2549)
Studies
(u-50488)
Trials
(u-50488)
Recent Studies (post-2010) (u-50488)
6001,6643209

Protein Interaction Comparison

ProteinTaxonomymrz 2549 (IC50)u-50488 (IC50)
Delta-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorMus musculus (house mouse)0.0027
Mu-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.7171
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.0958
Kappa-type opioid receptorHomo sapiens (human)0.0537

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fitzjarrell, AT; Heath, RG; Walker, CF1

Other Studies

1 other study(ies) available for mrz 2549 and u-50488

ArticleYear
Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys.
    Biological psychiatry, 1984, Volume: 19, Issue:7

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Behavior, Animal; Benzomorphans; Brain; Computers; Cyclazocine; Dose-Response Relationship, Drug; Electroencephalography; Ethylketocyclazocine; Evoked Potentials; Macaca mulatta; Naloxone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa

1984